Skip to main content

Lena Bugge Nordberg

Postdoc
https://orcid.org/0000-0001-6809-0573
See Google Scholar profile
See publications in PubMed

Education

  • Doctor (MD) at the Faculty of Medicine, University of Oslo (2012)
  • Doctoral degree at the Faculty of Medicine, University of Oslo (2019)

Position

  • Post.doc. (50%) in rheumatology, Diakonhjemmet hospital
  • Doctor in specialization (50%) internal medicine/rheumatology, Diakonhjemmet Hospital

Field of interest

  • Inflammatory joint diseases
  • Rheumatoid arthritis
  • Extra-articular manifestations in rheumatoid arthritis
  • Interstitial lung disease in rheumatoid arthritis
  • Ultrasound
  • Joint injections

Other

  • In the organizing committee for Green Congress

Email

This email address is protected from programs that collect email addresses. You need JavaScript enabled to view it.

Telephone

visiting address

Diakonhjemmet hospital
Forstanderboligen
Reidar Kobros vei 8
0370 Oslo

Postal address

Diakohjemmet hospital
PO Box 23 Vinderen
0319 Oslo

Projects

WP1 - Optimized medical interventions

ARCTIC

Remission in patients with rheumatoid arthritis: a randomized controlled trial investigating the use of ultrasound in clinical follow-up

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercise ullamco laboris nisi ut aliquip ex ea commodo consequat.
WP1 - Optimized medical interventions

ARCTIC FORWARD

10-year follow-up of patients with rheumatoid arthritis who received structured treatment-to-target therapy in the early disease phase.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercise ullamco laboris nisi ut aliquip ex ea commodo consequat.

Publications

Publications taken from the National Science Archive (NVA):

Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity

2024

Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trials

2024

Cooperation across healthcare service levels for medication reviews in older people with polypharmacy admitted to a municipal in-patient acute care unit (The COOP II Study): study protocol for a randomized controlled trial

2024

Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment

2021

Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy

2021

Conventional versus ultrasound treat to target: No difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis

2020

Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial

2018

The impact of ultrasound on the use and efficacy of intraarticular glucocorticoid injections in early rheumatoid arthritis: Secondary analyzes from a randomized trial examining the benefit of ultrasound in a clinical tight control regimen

2018

Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria

2017

Ultrasound in the management of rheumatoid arthritis: ARCTIC randomized controlled strategy trial

2016